Search the Newsreel

PriceSmart, Inc. $PSMT Shares Purchased by California State Teachers Retirement System

The California State Teachers Retirement System increased its stake in PriceSmart (NASDAQ:PSMT) by 22.7% in the first quarter, acquiring an additional 5,680 shares. This brings their total holdings to 30,720 shares, valued at approximately $4.6 million. Other institutional investors also raised their positions, with …

ResMed (RMD) Stock Drops As Margin Strength Meets Higher Expectations

CubeSmart (CUBE) Institutional Ownership 2026 $CUBE

This article details the institutional ownership of CubeSmart (NYSE:CUBE), including the percentage of stock owned by institutions, major buyers and sellers, and specific quarterly holdings by various firms. It highlights that institutional investors own 97.61% of CubeSmart's stock, with BlackRock Inc., Vanguard Group Inc., …

CubeSmart (CUBE) Q2 2026 Earnings Call Transcript

CubeSmart (CUBE) announced its Q2 2026 earnings, highlighting a return to positive growth with same-store revenue increasing by 0.8% year over year and FFO at $0.63 per diluted share. The company updated its full-year guidance, anticipating continued top-line acceleration and moderating expense growth in …

ResMed Price Target Raised to $244.00/Share From $234.00 by RBC Capital

RBC Capital has increased its price target for ResMed (RMD) shares to $244.00, up from the previous target of $234.00. This adjustment maintains an "Outperform" rating on the stock. The new price target suggests a potential upside from its last closing price of $219.00.

ResMed’s Q4 Earnings Beat Street Estimates, But FY27 Guidance Hides the Real Growth Rate.

Resmed Inc Stock (RMD) Closed Down by 5.22% on Aug 7: What Investors Need To Know

Resmed Inc (RMD) saw its stock close down by 5.22% on August 7th due to factors including gross margin contraction, concerns over GLP-1 weight-loss drugs impacting the CPAP market, and increased competition. The company's latest quarterly earnings revealed margin pressure from shifting product mix …

PriceSmart beats Q3 revenue estimates but misses on earnings; Shares edge lower

PriceSmart Inc. reported mixed third-quarter results, with revenue of $1.48 billion exceeding analyst expectations of $1.42 billion, an increase of 12.5% year-over-year. However, earnings per diluted share came in at $1.28, missing the consensus estimate of $1.32, causing shares to fall 1.6% after hours. …

AustralianSuper Pty Ltd reveals 5.71% holding in ResMed Inc (NYSE: RMD)

AustralianSuper Pty Ltd has disclosed a significant passive ownership stake of 5.71% in ResMed Inc. This holding amounts to 8,276,381 ordinary shares, over which AustralianSuper Pty Ltd maintains sole voting and dispositive power. The disclosure was made via a Schedule 13G filing, indicating an …

ResMed Inc. (NYSE:RMD) Plans Quarterly Dividend of $0.66

ResMed Inc. (NYSE:RMD) has declared a quarterly dividend of $0.66 per share, a 10% increase from its previous dividend, payable on September 24 to shareholders of record on August 20. The medical equipment provider's annualized dividend yields approximately 1.3% and is supported by a …

Will Strong Q2 Results, Buybacks and Higher Guidance Change CubeSmart's (CUBE) Narrative

CubeSmart (CUBE) reported strong Q2 2026 results with increased revenue and net income, alongside a share repurchase program and quarterly dividend. The company also raised its full-year earnings guidance, including a higher EPS range and improved same-store revenue and net operating income outlook. Despite …

Resmed Inc (RMD) Earnings Forecast: Future EPS & Revenue Growth Estimates

ResMed shares tumble as weak 2027 sales forecast eclipses quarterly profit beat

ResMed shares fell by about 6% after the company projected fiscal 2027 revenue below Wall Street expectations, largely due to the suspension of its Astral ventilator sales following an FDA recall. The company's revised guidance assumes no Astral ventilator sales in fiscal 2027, impacting …

ResMed (RMD) investor Michael Farrell plans 4,991-share stock sale after option exercise

ResMed (RMD) investor Michael Farrell has filed a Form 144 indicating a proposed sale of 4,991 shares of common stock on August 7, 2026, following a stock option exercise. The shares are intended to be sold for cash via Fidelity Brokerage Services LLC on …

RBC Capital Adjusts PT on ResMed to $244 From $234, Maintains Sector Perform Rating

RBC Capital has increased its price target for ResMed (RMD) to $244 from $234, while maintaining a Sector Perform rating on the stock. This adjustment comes shortly after ResMed reported its fiscal Q4 non-GAAP earnings and revenue were up, though shares initially fell.

ALTIN YUNUS ÇEŞME TURİSTİK TESİSLER A.Ş.(AYCES) Katılım Finansı İlkeleri Bilgi Formu 6 Ağustos 2026

Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

The Trade Desk (NASDAQ: TTD) reported weaker-than-expected Q2 financial results, with earnings per share missing estimates by 15% and revenue falling short of Street estimates. This news caused Trade Desk shares to drop significantly in pre-market trading, impacting other stocks such as Sezzle, Quidelortho, …

Resmed Reports Strong Q4 Results and Dividend Increase

Resmed (RMD) reported strong Q4 and full-year fiscal 2026 results, with revenue up 9% and 10% respectively, and a 17% increase in non-GAAP diluted EPS. The company generated significant free cash flow, returned $1.0 billion to shareholders, and raised its quarterly dividend by 10% …

ResMed Inc (RMD) (Q4 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ...

ResMed Inc. reported strong Q4 FY2026 results with a 9% headline revenue growth and a 16% increase in non-GAAP EPS, achieving 10% revenue growth and $1.6 billion in free cash flow for the full fiscal year. The company plans to return over $1.85 billion …

ResMed beats on earnings and ups dividend, yet shares plummet

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026

Resmed Inc. (NYSE: RMD, ASX: RMD) announced strong results for its fourth quarter and full fiscal year 2026, with Q4 revenue up 9% to a record $1.5 billion and non-GAAP diluted earnings per share increasing 16% to $2.95. The company returned $1.0 billion to …

ResMed Fiscal Q4 Non-GAAP Earnings, Revenue Up

ResMed reported increased non-GAAP earnings and revenue for its fiscal fourth quarter. The company's financial performance demonstrates growth during this period.

ResMed Introduced Guidance at Request of Investors, CEO Says

ResMed's CEO, Mick Farrell, explained that the company reintroduced financial guidance due to investor requests for more transparency regarding its growth prospects and market leadership. The decision comes after the company had previously paused guidance during the COVID-19 pandemic. This move aims to provide …

Analysts Offer Insights on Real Estate Companies: Omega Healthcare (OHI) and Cubesmart (CUBE)

RBC Capital analysts have provided insights on two real estate companies: Omega Healthcare (OHI) and Cubesmart (CUBE). Michael Carroll maintained a Hold rating on Omega Healthcare with a $51.00 price target, while Brad Heffern maintained a Buy rating on Cubesmart with a $47.00 price …

ResMed Inc. 2026 Q4 - Results - Earnings Call Presentation (NYSE:RMD) 2026-08-06

ResMed (NYSE:RMD) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops

ResMed (RMD) Q4 Earnings and Revenues Top Estimates

Earnings Flash (RMD) Resmed Inc. Posts Q4 Adjusted EPS $2.95 per Share, vs. FactSet Est of $2.89

Resmed Inc. (RMD) reported Q4 adjusted EPS of $2.95, surpassing the FactSet estimate of $2.89. The company's fiscal Q4 revenue was $1.46 billion, matching FactSet's estimate. Despite the positive earnings and revenue growth, ResMed's shares fell by 5%, indicating a perceived slowdown in growth.

Earnings Flash (RMD) Resmed Inc. Reports Q4 Revenue $1.46B, vs. FactSet Est of $1.46B

Resmed Inc. (RMD) reported its Q4 revenue at $1.46 billion, which matched the FactSet estimate. This financial update indicates the company's performance aligned with market expectations for the quarter. The news was released by MT Newswires.

Peter Farrell Sells 8,000 Shares of ResMed (NYSE:RMD) Stock

ResMed director Peter Farrell sold 8,000 shares of the company's stock for $1.8 million, reducing his holdings by 13.16% to 52,773 shares. The transaction, conducted under a Rule 10b5-1 trading plan, occurred on August 5th. ResMed's stock saw a slight increase of 0.1% to …

Resmed raises quarterly dividend 10% to $0.66 per share

Resmed reported strong Q4 FY2026 results with record revenue of $1.46 billion, up 9%, and non-GAAP EPS up 16%. For the full year FY2026, revenue increased 10% to $5.65 billion, with non-GAAP diluted EPS growing 17% to $11.17. The company also announced a 10% …

PriceSmart Inc (PSMT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for PriceSmart Inc (PSMT), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 4 analysts, the stock has an average price target of $112.50 and most analysts support a "Buy" trend. The article …

ResMed Inc. (NYSE: RMD) grows FY 2026 revenue to $5,653M and lifts dividend

ResMed Inc. reported strong financial results for fiscal year 2026 and the fourth quarter, with annual revenue increasing 10% to $5,653 million and non-GAAP diluted EPS rising 17% to $11.17. The company also announced a 10% increase in its quarterly cash dividend to $0.66 …

Resmed director Peter C. Farrell sells $1.8m in stock By Investing.com

ResMed director Peter C. Farrell sold 8,000 shares of company common stock for $1.8 million on August 5, 2026, under a Rule 10b5-1 trading plan. This transaction leaves him with 52,773 shares directly held. The sale occurred as ResMed's stock has declined by approximately …

ResMed (RMD) Faces An Earnings Test After A Rebound That Still Looks Undervalued

ResMed (RMD) is approaching its next earnings report with Wall Street anticipating $2.90 per share and $1.46 billion in revenue. Despite recent share price gains, the stock remains undervalued according to the most popular narrative, which sets a fair value of $247.93 compared to …

Form 144 ResMed INC For: 6 August By Investing.com

This article announces the filing of Form 144 for ResMed INC on August 6. Form 144 indicates an intent to sell restricted securities. The brief article, published by Investing.com, provides no further details beyond the filing announcement.